CD33 and neoplasm: Various tumor-derived factors have been reported to induce immature myeloid cells (CD33+ cells) to differentiate to MDSCs, these factors include prostaglandin E2, IL-6, IL-10, IL-1β, TGF-β, and proangiogenic factors such as vascular endothelial growth factor (35, 36).